A Targeted Approach
Our approach to oncology drug development is tailored to meet the specifics of your compound and in-line with the preclinical work that you have already done.
Data Driven – Oncology drug development is guided by data. Our clinical approach, therefore, will be based on your existing preclinical data.
Results Orientated – Our focus is on achieving results in the most expedited manner.
Whether a biological or a small molecule, vaccine or a chemotherapeutic, we have the expertise to transition your compound to clinical stage.
Clinical Research
Transitioning a compound from the pre-clinical to clinical is a complex and multi-step process. Our seasoned experts specialize in this very sensitive stage of the life cycle of new oncology products.
Discovering Facts
With the enrollment of the first few patients, we will start learning important facts about the safety and efficacy of your drug. We team with the investigators and will co-monitor the well-being of every study subject.
Data Analysis
With gradual and steady flow of clinical data, our team focuses on discovering potential trends. We analyze the data on regular intervals to detect potential safety and efficacy signals. The data will then be incorporated in the product’s investigator’s brochure.
Study Report
At the conclusion of the study, our team will prepare a comprehensive clinical study report for you. In addition, we will provide you with our expert opinion about the next logical steps and the path for the future development of your drug.
Discover the Future
We look forward to partnering with you and to transition your drug from its pre-clinical to clinical stage.